home / stock / govxw / govxw news

GOVXW News and Press, GeoVax Labs Inc. Warrants From 08/04/21

Stock Information
Company Name: GeoVax Labs Inc. Warrants
Stock Symbol: GOVXW
Market: NASDAQ
Website: geovax.com
Menu
GOVXW GOVXW Quote GOVXW Short GOVXW News GOVXW Articles GOVXW Message Board
Get GOVXW Alerts

News, Short Squeeze, Breakout and More Instantly...
GOVXW - GeoVax to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update

Conference call to be held Wednesday, August 11, at 4:30 p.m. Eastern Time ATLANTA, GA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing huma...
GOVXW - GeoVax Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting

GeoVax Vaccine Achieves 100% Protection in a Single-Dose ATLANTA, GA, July 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines, today announced the presentation of data from ...

GOVXW - GeoVax Announces Issuance of Hepatitis B Vaccine Patent

Vaccine Would Address Therapeutic Medical Need of Over 250 Million Worldwide ATLANTA, GA, July 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX) (“GeoVax” or the “Company”), a biotechnology company develop...

GOVXW - GeoVax to Participate in the Alliance Global Partners' Virtual Healthcare Symposium

Atlanta, GA, June 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc . (Nasdaq: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancers, announced today that it will be participating in the Allia...
GOVXW - GeoVax to Present at 2021 BIO Digital

GeoVax Chairman & CEO to Participate in Vaccine Panel Discussion ATLANTA, GA, June 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc . (Nasdaq: GOVX), a biotechnology company developing human immunotherapies and vaccines against infe...

GOVXW - GeoVax Reports 2021 First Quarter Financial Results and Provides Corporate Update

Additional Capital Raised to Support Acceleration of Coronavirus and Immuno-Oncology Programs ATLANTA, GA, May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing immunotherapies and vaccines a...

GOVXW - GeoVax to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021

GeoVax Chairman & CEO David Dodd to Participate in Panel Discussion ATLANTA, GA, May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc . (NasdaqCM: GOVX), a biotechnology company developing human immunotherapies and vaccines agai...
GOVXW - GeoVax to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update

Conference call to be held Thursday, May 6, at 4:30 p.m. Eastern Time ATLANTA, GA, April 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company develop...

GOVXW - GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent

Therapeutic Vaccine Would Address Medical Need of Over 250 Million Worldwide Atlanta, GA, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company deve...

GOVXW - GeoVax Reports 2020 Year-End Financial Results And Provides Corporate Update

COVID-19 Vaccine Designed as Single-Dose Against Multiple Strains Immuno-Oncology Programs Advancing ATLANTA, GA, March 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing immunotherapie...
Previous 10 Next 10